Diane King
Psychiatry · Barrington, RINPI 1144496720
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 458 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2022 at $1,635 and has fallen 79.1% since, to $343 in 2025. Among psychiatry clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $14.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Sunovion Pharmaceuticals Inc.$709
- Lundbeck LLC$646
- Takeda Pharmaceuticals U.S.A., Inc.$457
- Corium, LLC$347
- plus $1K from 8 others
What the payments were for
- Food & beverage$6,462100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 167 | $1,980 |
| Otsuka America Pharmaceutical, Inc. | 77 | $1,308 |
| Sunovion Pharmaceuticals Inc. | 51 | $709 |
| Lundbeck LLC | 54 | $646 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $457 |
| Corium, LLC | 21 | $347 |
| Vanda Pharmaceuticals Inc. | 15 | $297 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $214 |
| Alkermes, Inc. | 11 | $175 |
| Axsome Therapeutics, Inc. | 9 | $172 |
| Shire North American Group Inc | 3 | $72 |
| Orexo US, Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Biodelivery Sciences International, Inc. | 2 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$229
- ABILIFY MAINTENA$123
- ABILIFY ASIMTUFII$123
How this compares
$6,474 in reported general payments places this provider in the 90th percentile of 209 psychiatry providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 35 | $4,300 |
| Bupropion XlBupropion Hcl | 32 | $1,264 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $1,210 |
| Methylphenidate Hcl | 34 | $813 |
| Alprazolam | 66 | $805 |
| Temazepam | 22 | $632 |
| Duloxetine Hcl | 11 | $595 |
| Clonazepam | 87 | $499 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $471 |
| Bupropion Hcl SrBupropion Hcl | 23 | $404 |
| Fluoxetine Hcl | 34 | $372 |
| Risperidone | 20 | $336 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $327 |
| Gabapentin | 13 | $210 |
| Escitalopram Oxalate | 21 | $198 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Barrington
- Richard MillerCranston$864K
- Warren OngWarwick$807K
- James GreerProvidence$780K
- Mark ZimmermanCranston$225K
- Liliya KoyfmanWarwick$110K
- Linda CarpenterProvidence$37K
- Gene JacobsCranston$27K
- Terrie MailhotWarwick$26K
- Ethan KischWarwick$24K
- Monissa SolbergRiverside$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.